Sempulse® to Demonstrate and Showcase the Halo™ Vital Signs Monitoring System at the Operational Medicine Symposium 2025
San Antonio, TX – March 14, 2025 – Sempulse, a leader in wearable medical technology, is pleased to announce its sponsorship and participation in the 7th Annual Operational Medicine Symposium (OpMed) & Technology Showcase, scheduled for March 18-19, 2025, at the JW Marriott San Antonio Hill Country in San Antonio, TX.
OpMed is one of North America’s most influential military and emergency medical events, bringing together senior medical officials, clinicians, government leaders, and solution providers. The symposium offers a unique opportunity to learn, network, and engage with military medical professionals in an information-driven, networking-focused environment.
Sempulse will be exhibiting at Booth #123, where attendees can experience live demonstrations of the FDA-cleared Halo™ Vital Signs Monitoring System. This innovative, non-invasive device adheres [RF1] discreetly behind the ear and continuously captures the five major vital signs—SpO₂, pulse rate, respiratory rate, core body temperature, and skin temperature. During the conference, visitors [RF2] can observe their vital signs in real-time, even while in motion, highlighting the device’s capability to provide accurate data in dynamic environments.
The audience at OpMed comprises military, field, and emergency medical professionals dedicated to advancing combat casualty care, medical readiness, and healthcare services for U.S. military personnel. Sempulse’s participation aligns with its mission to innovate field triage and austere medicine, supporting first responders in saving more lives through real-time physiological monitoring.
“We are excited to engage with the military and austere medical community at OpMed 2025,” said Kurt Stump, founder and Chief Executive Officer of Sempulse. “Our Halo system is designed to enhance decision-making in critical situations, and we look forward to demonstrating its potential to the professionals committed to advancing medical readiness and combat casualty care.”
For more information about the Sempulse Halo Platform and the company’s mission to save lives, visit sempulse.com.
About Sempulse:
Founded in 2016, Sempulse is a medical device manufacturer with offices in San Marcos, TX. They are a leading innovator in wearable medical technology. They have developed and patented the first true FDA-cleared medical wearable: a novel, non-invasive vital signs sensor that adheres to the neck and the back of the ear and acquires multiple patients’ vital signs while at rest or on the go, including SpO2, pulse rate, respiratory rate, core body temperature, and skin temperature, plus geolocation and a wealth of environmental information. Sempulse empowers first responders, clinicians, and industry with real-time physiological data inside or out of the hospital, improving patient outcomes when every second counts.
Sempulse’s Halo Platform recently saved its first life. The Sempulse Halo, including the Halo sensor device, the LiveCharts app, and the Command Cloud application, provided real-time physiological data that led to life-saving action in Gwinnett County, GA.
About the Operational Medicine Symposium (OpMed):
The Operational Medicine Symposium & Technology Showcase is one of the largest and most influential military medical events in North America. It brings together senior medical officials, clinicians, government leaders, and solution providers to learn, network, and engage in an information-driven, networking-focused environment. The 2025 symposium will focus on improving healthcare services for U.S. military personnel, driving forward cutting-edge innovations in combat casualty care, enhancing medical education and training, and strengthening the medical readiness of the Joint Force.
###
If you would like more information about this topic or to speak with the CEO, please email pr@sempulse.com.